NEW
YORK, Aug. 1, 2022 /PRNewswire/ -- Shareholder
rights law firm Julie & Holleman has launched an investigation
into the proposed acquisition of Convey Health Solutions Holdings,
Inc. (NYSE: CNVY) by its principal shareholder, TPG Capital.
To learn more about the investigation, click here.
Through its funds, TPG already owns approximately 75% of Convey
Health's outstanding shares of common stock. Under the companies'
merger agreement, announced on June 21,
2022, TPG will acquire the remaining outstanding shares of
Convey Health for $10.50 per share in
cash, which represents an enterprise value for the company of
approximately $1.1 billion.
Julie & Holleman is investigating potential legal claims
available to Convey Health's shareholders regarding the proposed
acquisition, including claims relating to TPG's and management's
conflicts of interest and the adequacy of the $10.50 per share acquisition price.
If you would like more information about Julie & Holleman's
investigation, or about the acquisition in general, please contact
W. Scott Holleman by email at
scott@julieholleman.com or by telephone at (929) 415-1020. You may
also visit the firm's website by clicking here.
Julie & Holleman is a boutique law firm that focuses on
shareholder litigation, including derivative actions, mergers and
acquisitions cases, securities fraud class actions, and corporate
investigations. The firm's attorneys litigate in state and federal
courts across the nation. For more information about the firm,
please visit www.julieholleman.com. This notice may constitute
attorney advertising.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cnvy-alert-julie--holleman-investigates-potential-legal-claims-related-to-proposed-acquisition-of-convey-health-solutions-holdings-inc-301597112.html
SOURCE Julie & Holleman LLP